TG

Tredegar Corporation
$7.80
+0.14 (+1.83%)
Mkt Cap 272.21M
Volume 101,278
52W Range 6.25-10.53
Sector Industrials
Beta 0.78
EPS (TTM) 0.96 USD
P/E Ratio 8.12
Revenue (TTM) 781.74M USD
Rev Growth (5Y) -0.9%
EPS Growth (5Y) +2.8%
AlphaVal · Fair Value
What we estimate one share is worth
$14.40
Undervalued strong signal
45.8% below fair value
Modeled from cash flows & growth.
AlphaQuality · Grade · Gated
How strong & durable the business is
F
Stable Earnings Power
30.0 / 100 pillar composite (overridden)
Steady, predictable earnings power — graded A–F vs. similar companies.

Company Description

Track Record

Showing latest 4 periods • Swipe for more
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue 722.86M 598.02M 573.32M 761.99M 826.46M 755.29M 826.32M 851.83M 961.33M 828.34M 896.18M 951.83M
Net Income 33.48M (64.56M) (105.91M) 28.45M 57.83M (75.44M) 48.26M 24.84M 38.25M 24.47M (32.13M) 36.88M
EPS 0.96 -1.88 -3.10 0.84 1.72 -2.26 1.45 0.75 1.16 0.75 -0.99 1.14
Free Cash Flow 15.74M 11.16M (2.45M) (57.72M) 43.22M 51.02M 65.00M 56.98M 43.85M 3.42M 41.42M 6.34M
FCF / Share 0.45 0.32 -0.07 -1.71 1.29 1.53 1.96 1.72 1.33 0.10 1.27 0.20
Operating CF 32.98M 25.51M 24.00M (20.84M) 70.58M 74.37M 115.86M 97.79M 88.22M 48.87M 74.26M 51.23M
Total Assets 371.37M 356.36M 446.46M 572.16M 523.58M 514.87M 712.67M 707.37M 755.74M 651.16M 623.26M 788.63M
Total Debt 48.27M 77.37M 158.62M 151.77M 87.99M 151.03M 61.77M 101.50M 152.00M 95.00M 104.00M 137.25M
Cash & Equiv 6.73M 7.06M 9.66M 19.23M 30.52M 11.85M 31.42M 34.40M 36.49M 29.51M 44.16M 50.06M
Book Value 216.55M 180.97M 155.65M 201.76M 184.72M 109.06M 376.75M 354.86M 343.78M 310.78M 272.75M 372.03M
Return on Equity 0.15 -0.36 -0.68 0.14 0.31 -0.69 0.13 0.07 0.11 0.08 -0.12 0.10
TG News
Tredegar Announces Election of Ana Dutra to Board of Directors
Aug 20, 2026 01:32 PM · businesswire.com
Tredegar Q2 Earnings Rise Y/Y on Aluminum Extrusions Gains
Aug 13, 2026 11:15 AM · zacks.com
Tredegar (NYSE:TG) Share Price Crosses Above 200 Day Moving Average – Here’s Why
Aug 11, 2026 10:23 PM · defenseworld.net
Tredegar Reports Second Quarter 2026 Results
Aug 07, 2026 04:15 AM · businesswire.com
Tredegar Plans to Release Second Quarter 2026 Financial Results on August 7, 2026
Aug 03, 2026 04:55 AM · businesswire.com
Tredegar Announces the Retirement of Frasier W. Brickhouse II, Chief Financial Officer, Treasurer and Vice President, Effective September 1, 2026
Jul 30, 2026 01:58 PM · businesswire.com
Arrowhead Pharmaceuticals Reports Topline Results from Phase 3 SHASTA-3 and SHASTA-4 Studies of Plozasiran in Patients with Severe Hypertriglyceridemia
Jul 22, 2026 04:00 AM · gurufocus.com
TRYNGOLZA® (olezarsen) approved by the FDA as the first and only treatment to reduce triglycerides and the risk of acute pancreatitis in patients with severe hypertriglyceridemia (sHTG)
Jun 24, 2026 11:00 AM · gurufocus.com
Trifecta Gold Increases Private Placement
Jun 17, 2026 04:00 AM · accessnewswire.com
Grafton Group Sets 2030 Growth Targets as Cash Flow and Acquisitions Take Center Stage
Jun 11, 2026 09:04 AM · marketbeat.com